Simple, effective and safe vascular access site closure with the double-ProGlide preclose technique in 162 patients receiving transfemoral transcatheter aortic valve implantation

Catheterization and Cardiovascular Interventions

Volumn 82, Issue 5, 2013, Pages

  Griese, Daniel P ^a   Reents, Wilko ^b   Diegeler, Anno ^b   Kerber, Sebastian ^a   Babin Ebell, Jörg ^b  

^a Cardiovascular Center Bad Neustadt   (Germany)

^b Cardiovascular Clinic Bad Neustadt   (Germany)

Author keywords

Perclose ProGlide; transcatheter aortic valve implantation; transfemoral; vascular closure device

Indexed keywords

ANTITHROMBOCYTIC AGENT;

AGED; ARTERY DISSECTION; ARTERY OCCLUSION; ARTICLE; BLEEDING; FEMALE; HEPARINIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS AORTIC VALVE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; SAFETY; SUTURING METHOD; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT FAILURE; TREATMENT OUTCOME; VASCULAR ACCESS; VASCULAR DISEASE; VASCULAR SUTURE;

PERCLOSE PROGLIDE; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSFEMORAL; VASCULAR CLOSURE DEVICE;

AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; CARDIAC CATHETERIZATION; DRUG THERAPY, COMBINATION; FEASIBILITY STUDIES; FEMALE; FEMORAL ARTERY; HEART VALVE PROSTHESIS IMPLANTATION; HEMORRHAGE; HEMOSTATIC TECHNIQUES; HUMANS; MALE; PLATELET AGGREGATION INHIBITORS; PUNCTURES; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84886946981     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.25053     Document Type: Article

References (26)

1. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010; 363: 1597-1607.
2. Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011; 364: 2187-2198.
3. Linke A,. Treatment of high risk aortic stenosis with transcatheter Medtronic CoreValve implantation. JACC 2012; 59: E8-E8.
4. Gilard M, Eltchaninoff H, Iung B, et al. Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med 2012; 366: 1705-1715.
5. Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012): The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2012 [Epub ahead of print].
6. Haulon S, Hassen Khodja R, Proudfoot CW, Samuels E,. A systematic literature review of the efficacy and safety of the Prostar XL device for the closure of large femoral arterial access sites in patients undergoing percutaneous endovascular aortic procedures. Eur J Vasc Endovasc Surg 2011; 41: 201-213.
7. Hayashida K, Lefèvre T, Chevalier B, et al. Transfemoral aortic valve implantation-New criteria to predict vascular complications. JACC Cardiovasc Interv 2011; 4: 851-858.
8. Hayashida K, Lefèvre T, Chevalier B, et al. True percutaneous approach for transfemoral aortic valve implantation using the Prostar XL device: Impact of learning curve on vascular complications. JACC Cardiovasc Interv 2012; 5: 207-214.
9. Leon MB, Piazza N, Nikolsky E, et al. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: A consensus report from the Valve Academic Research Consortium. J Am Coll Cardiol 2011; 57: 253-269.
10. Webb JG, Chandavimol M, Thompson CR, et al. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation 2006; 113: 842-850.
11. Grube E, Laborde JC, Gerckens U, et al. Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: The Siegburg first-in-man study. Circulation 2006; 114: 1616-1624.
12. Cockburn J, de Belder A, Brooks M, et al. Large calibre arterial access device closure for percutaneous aortic valve interventions: Use of the Prostar system in 118 cases. Catheter Cardiovasc Interv 2012; 79: 143-149.
13. Al-Khatib WK, Zayed MA, Harris EJ, et al. Selective use of percutaneous endovascular aneurysm repair in women leads to fewer groin complications. Ann Vasc Surg 2012; 26: 476-482.
14. Krajcer Z, Nelson P, Bianchi C, et al. Percutaneous endovascular abdominal aortic aneurysm repair: Methods and initial outcomes from the first prospective, multicenter trial. J Cardiovasc Surg 2011; 52: 651-659.
15. Nelson P,. Percutaneous endovascular aortic aneurysm repair (PEVAR): Results from the first prospective, multicenter randomized trial. Presented at the 37th annual meeting of the SAVS, January 23-26, 2013.
16. Krajcer Z,. Results of the PEVAR multicenter, randomized trial. Presented at the 25th annual meeting of the ISET, January 19-23, 2013.
17. Kahlert P, Eggebrecht H, Erbel R, Sack S,. A modified "preclosure" technique after percutaneous aortic valve replacement. Catheter Cardiovasc Interv 2008; 72: 877-884.
18. Kahlert P, Al-Rashid F, Plicht B, et al. Suture-mediated arterial access site closure after transfemoral aortic valve implantation. Catheter Cardiovasc Interv 2012 [Epub ahead of print].
19. Toggweiler S, Gurvitch R, Leipsic J, et al. Percutaneous aortic valve replacement. Vascular outcomes with a fully percutaneous procedure. JACC Cardiovasc Interv 2012; 59: 113-118.
20. Zahn R, Gerckens U, Grube E, et al. Transcatheter aortic valve implantation: First results from a multi-centre real-world registry. Eur Heart J 2011; 32: 198-204.
21. Piazza N, Grube E, Gerckens U, et al. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: Results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention 2008; 4: 242-249.
22. Bosmans JM, Kefer J, De Bruyne B, et al. Procedural, 30-day and one year outcome following CoreValve or Edwards transcatheter aortic valve implantation: Results of the Belgian national registry. Interact Cardiovasc Thorac Surg 2011; 12: 762-767.
23. Lefèvre T, Kappetein AP, Wolner E, et al. One year follow-up of the multi-centre European PARTNER transcatheter heart valve study. Eur Heart J 2011; 32: 148-157.
24. Willis P, Voeltz MD,. Anemia, hemorrhage, and transfusion in percutaneous coronary intervention, acute coronary syndromes, and ST-segment elevation myocardial infarction. Am J Cardiol 2009; 104: 34C-38C.
25. Doyle BJ, Rihal CS, Gastineau DA, Holmes DR Jr,. Bleeding, blood transfusion, and increased mortality after percutaneous coronary intervention: Implications for contemporary practice. J Am Coll Cardiol 2009; 53: 2019-2027.
26. Ducrocq G, Francis F, Serfaty JM, et al. Vascular complications of transfemoral aortic valve implantation with the Edwards SAPIEN prosthesis: Incidence and impact on outcome. EuroIntervention 2010; 5: 666-672.